Bilirubin

"Bilirubin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A bile pigment that is a degradation product of HEME.

Descriptor ID	D001663
MeSH Number(s)	D03.383.129.578.840.249.184 D03.633.400.909.249.184 D04.345.783.249.184 D23.767.193.184
Concept/Terms	Bilirubin Bilirubin Bilirubin IX alpha Bilirubin, (4E)-Isomer Bilirubin, (4E)-Isomer Bilirubin, (4E,15E)-Isomer Bilirubin, (4E,15E)-Isomer Hematoidin Hematoidin Bilirubin, Disodium Salt Bilirubin, Disodium Salt Disodium Salt Bilirubin Bilirubin, Monosodium Salt Bilirubin, Monosodium Salt Monosodium Salt Bilirubin delta-Bilirubin delta-Bilirubin delta Bilirubin Bilirubin, (15E)-Isomer Bilirubin, (15E)-Isomer Bilirubin, Calcium Salt Bilirubin, Calcium Salt Calcium Salt Bilirubin Salt Bilirubin, Calcium Calcium Bilirubinate Bilirubinate, Calcium

Below are MeSH descriptors whose meaning is more general than "Bilirubin".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Pyrroles [D03.383.129.578]
Tetrapyrroles [D03.383.129.578.840]
Bile Pigments [D03.383.129.578.840.249]
Bilirubin [D03.383.129.578.840.249.184]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 4 or More Rings [D03.633.400]
Tetrapyrroles [D03.633.400.909]
Bile Pigments [D03.633.400.909.249]
Bilirubin [D03.633.400.909.249.184]
Polycyclic Compounds [D04]
Macrocyclic Compounds [D04.345]
Tetrapyrroles [D04.345.783]
Bile Pigments [D04.345.783.249]
Bilirubin [D04.345.783.249.184]
Biological Factors [D23]
Pigments, Biological [D23.767]
Bile Pigments [D23.767.193]
Bilirubin [D23.767.193.184]

Below are MeSH descriptors whose meaning is related to "Bilirubin".

Below are MeSH descriptors whose meaning is more specific than "Bilirubin".

Bilirubin
Biliverdine

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Bilirubin" by people in this website by year, and whether "Bilirubin" was a major or minor topic of these publications.

Bar chart showing 16 publications over 12 distinct years, with a maximum of 2 publications in 2007 and 2010 and 2013 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2007	0	2	2
2008	1	0	1
2010	1	1	2
2011	1	0	1
2012	1	0	1
2013	0	2	2
2014	1	0	1
2016	1	0	1
2017	0	2	2
2018	0	1	1
2023	1	0	1
2025	1	0	1

Below are the most recent publications written about "Bilirubin" by people in Profiles.

Sharma S, Vishwakarma J, Czub J, Sappati S, Gavvala K. Elucidation of the Synergistic Interaction Between Bilirubin and Casein Protein: An Integrated Spectroscopy and Computational Approach. Biomacromolecules. 2025 Aug 11; 26(8):5298-5309.

View in: PubMed
Heutlinger O, Mathew T, Fujimoto D, Bharani V, Yamarik R, Baz S. Bilirubin Elevation Caused by Naproxen Overdose: A Case Report Highlighting Laboratory Interference. Am J Case Rep. 2023 Oct 16; 24:e941267.

View in: PubMed
Leger P, Chirwa S, Nwogu JN, Turner M, Richardson DM, Baker P, Leonard M, Erdem H, Olson L, Haas DW. Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation. Pharmacogenet Genomics. 2018 Jan; 28(1):1-6.

View in: PubMed
Omobowale TO, Oyagbemi AA, Ajufo UE, Adejumobi OA, Ola-Davies OE, Adedapo AA, Yakubu MA. Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System. J Diet Suppl. 2018 Mar 04; 15(2):183-196.

View in: PubMed
Yan J, Xie G, Liang C, Hu Y, Zhao A, Huang F, Hu P, Liu P, Jia W, Wang X. Herbal medicine Yinchenhaotang protects against a-naphthylisothiocyanate-induced cholestasis in rats. Sci Rep. 2017 06 23; 7(1):4211.

View in: PubMed
Han J, Saraf SL, Zhang X, Gowhari M, Molokie RE, Hassan J, Alhandalous C, Jain S, Younge J, Abbasi T, Machado RF, Gordeuk VR. Patterns of opioid use in sickle cell disease. Am J Hematol. 2016 Nov; 91(11):1102-1106.

View in: PubMed
Chow D, Kohorn L, Souza S, Ndhlovu L, Ando A, Kallianpur KJ, Byron MM, Baumer Y, Keating S, Shikuma C. Atazanavir use and carotid intima media thickness progression in HIV: potential influence of bilirubin. AIDS. 2016 Feb 20; 30(4):672-4.

View in: PubMed
Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 01; 21(1):193-200.

View in: PubMed
Wey A, Wang L, Rudser K. Censored quantile regression with recursive partitioning-based weights. Biostatistics. 2014 Jan; 15(1):170-81.

View in: PubMed
Eley T, Huang SP, Conradie F, Zorrilla CD, Josipovic D, Botes M, Osiyemi O, Hardy H, Bertz R, McGrath D. Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1287-92.

View in: PubMed

People

Explore

Similar Concepts

Top Journals